No abstract available
MeSH terms
-
Adrenergic beta-Antagonists / administration & dosage
-
Adrenergic beta-Antagonists / adverse effects*
-
Antihypertensive Agents / administration & dosage
-
Antihypertensive Agents / adverse effects*
-
Benzothiadiazines
-
Calcium Channel Blockers / administration & dosage
-
Calcium Channel Blockers / adverse effects*
-
Controlled Clinical Trials as Topic
-
Diabetes Mellitus, Type 2 / prevention & control
-
Diuretics
-
Drug Therapy, Combination
-
Humans
-
Risk Factors
-
Sodium Chloride Symporter Inhibitors / administration & dosage
-
Sodium Chloride Symporter Inhibitors / adverse effects
-
Stroke / prevention & control
Substances
-
Adrenergic beta-Antagonists
-
Antihypertensive Agents
-
Benzothiadiazines
-
Calcium Channel Blockers
-
Diuretics
-
Sodium Chloride Symporter Inhibitors